Navigation Links
Increased Drug Related Cardiac Toxicity Leads Gwathmey Preclinical Testing Services to Create Novel Cardionomics(TM) Services for Preclinical Cardiac Safety Screening of Drug Candidates
Date:5/8/2008

hmey Preclinical Testing Services, Inc. has assembled a world-class physician and researcher advisory board for its Cardionomics(TM) Services. All Cardionomics(TM) Advisory Board members are highly-sought after scientists with vast experience and significant industry and academic excellence, as well as specialized expertise in running clinical trials. Furthermore, the panel members have taken concepts from the bench side all the way to clinical trials and therefore have extensive experience in navigating the FDA field.

"The Cardionomics Services and Advisory Board provide a unique approach and solution to prevent new drugs from posing cardiac risk. This kind of original and innovative thinking is typical of Dr. Gwathmey, who has been at the forefront of heart failure research for over 20 years," said Michael Bristow, M.D., Ph.D. founder of Myogen, and founder and CEO of ARCA Biopharma.

Gwathmey Preclinical Testing Services, Inc. Cardionomics(TM) Advisory Board Members include:

Gary Francis, M.D.

Section Head, Clinical Cardiology

Cleveland Clinic

Roger J. Hajjar, M.D.

Professor, Medicine / Cardiology Professor

Mt. Sinai Department of Gene and Cell Medicine

Barry M. Massie, M.D., F.A.C.C.

Chief, Cardiology Division

VA Hospital

University of California, San Francisco

Michael Rosen, M.D.

Professor of Pharmacology and Pediatrics

Columbia University College of Physicians and Surgeons

Stephen F. Vatner, M.D.

Chair, Cell Biology and Molecular Medicine, Professor

University of Medicine and Dentistry of New Jersey

About Gwathmey Preclinical Testing Services, Inc.

Gwathmey Preclinical Testing Services, Inc. supports biotechnology and pharmaceutical companies to meet their scientific and financial goals through a disciplined approach that maximizes quality, throughput and process efficiency. We are continually performing process improvement, th
'/>"/>

SOURCE Gwathmey Preclinical Testing Services, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Increased Light Leads to Early Detection: Caliper Life Sciences Introduces Bioware(R) Ultra Cancer Cell Lines
2. APIC Statement on Need for Increased Prevention Measures for Healthcare-Associated Infections (HAIs)
3. Kiwa Bio-Tech Animal Feed Volume Increased 25% in Fourth Quarter of 2007
4. Novo Nordisk Increased Operating Profit by 11% in the First Nine Months of 2007 Based on a 9% Sales Increase and an Improved Gross Margin
5. VaxGen Sells Anthrax Vaccine Program and Related Assets and Technology to Emergent BioSolutions, Inc.
6. Vasogen Receives NASDAQ Notification Related to Minimum Bid Price
7. Intellect Neurosciences, Inc. Receives Notice of Allowance and Completes Grant Requirements for Pivotal European Patent Related to Passive Immunization of Alzheimers Disease
8. District Judge Dismisses Shareholder Suit Related to Boston Scientific
9. Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX)
10. Alexion Acquires All Rights to OMRF Patents Related to Soliris(R)
11. TAP Pharmaceutical Products Inc. Files New Drug Application for TAK-390MR in Patients with Acid-Related Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... - iCo Therapeutics Inc. ("iCo" or "the Company") (TSX-V: ... Oral Amphotericin B (Oral Amp B) drug candidate ... ImmuneCarta®, the immune monitoring business unit of Caprion, ... Amp B in reactivating latent HIV viral reservoirs ... with antiretroviral therapy. Memory cells, ...
(Date:8/18/2014)... Tampa, FL (Aug. 18, 2014) -- A new ... South Florida (USF) Morsani College of Medicine and ... the life-threatening complications of interventional cardiovascular disease treatment. ... model that the novel molecular therapy could selectively ... healing following a medical procedure using a balloon ...
(Date:8/18/2014)... 2014   Sterne, Kessler, Goldstein & Fox P.L.L.C. ... Washington, DC , announced today that it has ... (IPR) with the U.S. Patent and Trademark Office (USPTO) ... Laboratories, Inc. (Nasdaq: BRLI).  These IPR petitions aim to ... Genetics, Inc. These patents have been asserted against GeneDx ...
(Date:8/18/2014)... YORK , August 18, 2014 ... published by Transparency Market Research "Life Science Reagents ... Flow Cytometry, Electrophoresis, Chromatography, In-Vitro Diagnostic Reagents and ... and Academic Institutions, Clinical Laboratories, and Forensic Laboratories)- ... Forecast, 2013 - 2019", the global life science ...
Breaking Biology Technology:iCo Therapeutics Announces Positive Oral Amphotericin B Study Results 2iCo Therapeutics Announces Positive Oral Amphotericin B Study Results 3Selective therapy may improve artery repair after interventional cardiovascular procedures 2Selective therapy may improve artery repair after interventional cardiovascular procedures 3Sterne Kessler Files 11 IPR Petitions On Behalf Of GeneDx, Inc., Subsidiary Of BioReference Laboratories, Inc. 2Sterne Kessler Files 11 IPR Petitions On Behalf Of GeneDx, Inc., Subsidiary Of BioReference Laboratories, Inc. 3Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 2Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 3Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 4Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 5
... Quarterly presents a 360-degree look at the "state of ... drugs. This CQ Forum will include a panel discussion ... regarding the complex structures of biologics products vs. traditional ... these products save money for consumers? What is the ...
... June 15 Hollis-Eden Pharmaceuticals, Inc. (Nasdaq: ... new class of small molecule compounds based on endogenous adrenal ... James M. Frincke Ph.D. as President and CEO of Hollis-Eden ... company,s board of directors. , , Dr. Frincke joined ...
... June 15 Nanopoint Inc., an award-winning developer ... announced that effective immediately its cellTRAY Imaging System ... European marketplace. Nanopoint,s cellTRAY Imaging and Fluidics Systems ... including drug discovery, assisted reproductive technology (ART), stem ...
Cached Biology Technology:Hollis-Eden Pharmaceuticals Announces Appointment of Dr. James M. Frincke President and CEO 2Hollis-Eden Pharmaceuticals Announces Appointment of Dr. James M. Frincke President and CEO 3Nanopoint Applies CE Mark to Its cellTRAY(R) Imaging and Microfluidics Systems 2
(Date:8/19/2014)... lemur. It,s not an African Bush Baby or even a ... downright "cool" primate from Southeast Asia. , "It,s really not ... Brown, curator-in-charge at the University of Kansas, Biodiversity Institute. "A ... body; a long tail with a furry tuft at the ... a bit like the disks on the digits of tree ...
(Date:8/19/2014)... retail seafood counters in 10 different states show ... to unexpectedly high levels of mercury, a harmful ... fish of the same species, but from a ... according to new research by University of Hawai,i ... is essential to allow consumers to choose sustainable ...
(Date:8/19/2014)... identified a biomarker strongly associated with basal-like breast ... to many types of chemotherapy. The biomarker, a ... new therapeutics designed to treat this often deadly ... from The Cancer Genome Atlas, molecular biologists Curt ... computational and bioinformatics techniques to detect patterns of ...
Breaking Biology News(10 mins):Philippine tarsier gets boost from Kansas research, and genetic proof of a new variety 2Philippine tarsier gets boost from Kansas research, and genetic proof of a new variety 3Seafood substitutions can expose consumers to unexpectedly high mercury 2Seafood substitutions can expose consumers to unexpectedly high mercury 3Biomarker in an aggressive breast cancer is identified 2Biomarker in an aggressive breast cancer is identified 3
... and vegetables instead of cookies and soda pop. Consider ... applaud a lunchtime workout rather than criticizing the cut ... encourages walking the stairs instead of riding the elevator. ... by Community Health Councils, Inc. (CHC) in Los Angeles ...
... Cold Spring Harbor Laboratory on Long Island have identified which ... the chief target of the widely prescribed antidepressant Prozac. This ... for depression, with fewer side effects, to be developed. , ... the factors that control how, when, and where new neurons ...
... tumor and settles in a new location, where it ... assays for this process, which is known as metastasis, ... across the surface of a matrix, traveling in a ... approach misses some crucial phenomena. , Working in the ...
Cached Biology News:UCLA study of community health project shows how group dynamics affect fitness, eating habits 2UCLA study of community health project shows how group dynamics affect fitness, eating habits 3Prozac's target revealed 23-D model reveals secrets of metastasis 2
normal human fibroblasts Source: Cell Lysate Form: Ready to Use Application: Western Blotting Control...
Purified anti-Fanconi anemia D2-Phosphorylated (Ser222)...
... processes up to 48 lanes, 24 bi-directional, ... can be from either slab gel or ... chemistries. The detection parameters in Explorer have ... consistency. We have built Explorer for ...
... Certified USDA Research Registered OLAW Assured AAALAC ... AALAS Certified Technicians Documentation ... Upon Request Focus CRP is ... your custom immunology service needs. We ...
Biology Products: